 ?您的位置：對照品 > 標準品 > 歐洲藥典標準品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：B287633 |
| 產(chǎn)品名稱：N-4-Benzyloxyphenyl α-Benzilidene-d5 Isobutyrylacetamide |
| 產(chǎn)品CAS：1020719-20-3 |
| 規(guī)格含量：50mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
B287633 |
| 名稱: |
N-4-Benzyloxyphenyl α-Benzilidene-d5 Isobutyrylacetamide |
| 別名: |
4-Methyl-3-oxo-N-[4-(phenylmethoxy)phenyl]-2-(phenyl-2,3,4,5,6-d5-methylene)pentanamimde; |
| CAS號: |
1020719-20-3 |
| 備用CAS: |
163217-66-1 unlabelled |
| 分子式: |
C??H??D?NO? |
| 外觀： |
白色固體 |
| 分子量: |
404.51 |
| 溶解度: |
Acetone, Chloroform, Dichloromethane, Ethyl Acetate |
| 類別: |
Building Blocks; Isotopic Labeled Analogues; |
| 應用: |
A deuterated intermediate of the metabolite of Atorvastin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia. |
| 文獻 |
|
|
|
|
|
|
